Sorry, you need to enable JavaScript to visit this website.
Skip to main content

All materials and content available on the website are of strictly non-promotional nature and only intended for healthcare professionals (HCPs) practicing in Europe. Kindly note that materials and content are not intended for any specific country and approval conditions for products may vary from country to country. Before prescribing any product, always refer to the approved label in the relevant country and/or the Summary of Product Characteristics.

  • March 20, 2024
  • CKD-associated pruritus

CKD-associated pruritus: Why the role of the nurse is pivotal to establish symptom based care in nephrology

Explore the science
  • March 18, 2024
  • Glomerular Disease

Endothelin-1 (ET-1) and Angiotensin II (ANG II) in IgA Nephropathy (IgAN) - Video

Explore the science
  • March 18, 2024
  • Glomerular Disease

Advancing Therapeutic Goals in IgA Nephropathy

Explore the science
  • March 18, 2024
  • Glomerular Disease

Target Proteinuria in IgA Nephropathy (IgAN)

Explore the science
  • March 18, 2024
  • Glomerular Disease

Endothelin-1 (ET-1) and Angiotensin II (ANG II) in IgA Nephropathy (IgAN) – Educational Presentation

Explore the science
  • March 18, 2024
  • Glomerular Disease

Immunoglobulin A Nephropathy (IgAN) explained – Educational Presentation

Explore the science
  • March 18, 2024
  • Glomerular Disease

IgA Nephropathy (IgAN) explained – 1 pager

Explore the science
  • March 18, 2024
  • Glomerular Disease

Proteinuria fact sheet

Explore the science
  • March 15, 2024
  • CKD-associated pruritus

Difelikefalin improves itch-related sleep disruption in patients undergoing haemodialysis

Explore the science